Gene expression analysis allows researchers to predict which patients will respond to flu vaccines and possibly expedite vaccine development.
Advertisement
The Scientist
Most Recent
New evidence supports an old idea that embryos with genetic abnormalities can somehow fix themselves early in development.
Ivan Martin talks about the promise of using cell-based therapies to regenerate joint cartilage.
The recipient of the first synthetic organ transplant—a synthetic trachea seeded with the patient’s own stem cells—is sent home from the hospital.
South Korea approves the first stem-cell medication for clinical use.
Three RNAs expressed in the nucleolus mediate death in cells exposed to too much fat.
A certain type of neural precursor does it all—replaces itself, differentiates into specialized brain cells, and multiplies into more stem-cell-like cells.
A new study finds that more than two thirds of Americans approve of the use of stem cells in research aiming to cure serious diseases.
The story of the US government’s efforts to stamp out smallpox in the early 20th century offers insights into the science and practice of mass vaccination.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
